﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>1</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2011</Year>
        <Month>06</Month>
        <DAY>15</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Vasorelaxant Effect of a Newly Synthesized Dihydropyridine Ethyl Ester (DHPEE) on Rat Thoracic Aorta: Dual Mechanism of Action</ArticleTitle>
    <FirstPage>10</FirstPage>
    <LastPage>17</LastPage>
    <ELocationID EIdType="doi">10.5681/apb.2011.002</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Babaei</LastName>
      </Author>
      <Author>
        <FirstName>Farzaneh</FirstName>
        <LastName>Ebrahimi</LastName>
      </Author>
      <Author>
        <FirstName>Javid</FirstName>
        <LastName>Shahbazi Mojarrad</LastName>
      </Author>
      <Author>
        <FirstName>Yadollah</FirstName>
        <LastName>Azarmi</LastName>
      </Author>
      <Author>
        <FirstName>Afsaneh</FirstName>
        <LastName>Gharehbagheri</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.5681/apb.2011.002</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2011</Year>
        <Month>05</Month>
        <Day>08</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: DHPEE is a newly synthesized compound by merging the key structural elements in an angiotensin receptor blocker (Telmisartan) with key structural elements in 1,4- dihydropyridine calcium channel blocker (Nifedipine). In this study, we examined dual calcium channel blocking and AT1 antagonist activity for DHPEE. Methods: The functional inhibitory characteristics of DHPEE were studied in vitro in rat thoracic aorta preparations precontracted by phenylephrine (1µM) or KCl (80µM) or Ang II in normal or calcium-free solutions. Results:Concentration–dependent significant relaxation was observed in aortic rings precontracted with phenylephrine, KCl or Ang II. The tension increment produced by increasing external calcium was also reduced by DHPEE. DHPEE caused a marked decrease in the maximal contractile response of the vasoactive agents and shifted their concentration-response curves to the right. Conclusion:DHPEE possesses dual characteristics and cause vasorelaxation by blocking the L-type calcium channels and blocking Ang II receptors (AT1) in rat aortic smooth muscle.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Angiotensin II</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Rat Aorta</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">DHPEE</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Calcium Channel blocker</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Angiotensin Receptor blocker</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>